Healthpeak’s Senior Housing Spinoff Janus Living Debuts at $6B Valuation, Beating IPO Targets
Healthpeak’s senior housing spinoff, Janus Living (JAN), outperformed IPO targets, opening at $23.50 per share amid a surge in demographic-driven investment.
By: AXL Media
Published: Mar 21, 2026, 7:21 AM EDT
Source: Bisnow

A Strong Public Market Entrance
The Janus Living initial public offering (IPO) was met with overwhelming demand, becoming oversubscribed within days of marketing. Healthpeak offered 42 million shares, attracting heavy interest from institutional heavyweights such as PGIM, DWS Group, and MFS Investment Management, who collectively signaled intent to purchase up to $300 million in shares. While Healthpeak retains a controlling 84% stake in the entity, the standalone structure allows Janus Living to operate with its own dedicated capital stack and growth strategy, insulated from the broader valuation "drag" currently affecting the life sciences sector.
Strategic Rationale and Portfolio Composition
Healthpeak CEO Scott Brinker’s decision to carve out the senior living division was driven by a desire to unlock value that was previously obscured by the firm's diverse holdings. Janus Living enters the market with a "seed" portfolio of 34 senior housing communities encompassing 10,422 beds. By isolating these assets, the firm can better cater to investors specifically seeking exposure to the "Silver Tsunami"—the demographic wave of aging baby boomers. This specialized focus is expected to command a premium valuation compared to diversified healthcare REITs, which are currently trading at lower multiples.
Regulatory and Competitive Landscape
The launch of Janus Living arrives during a period of intense consolidation and capital raising in the senior housing sector. Competitors like Kayne Anderson Real Estate and Fortress Investment Group have recently launched multi-billion dollar funds targeting the same "needs-based" assets. Janus Living’s public status gives it a distinct advantage in terms of transparency and access to the equity markets, allowing it to compete for large-scale portfolios that private equity firms might find too expensive to finance in a high-interest-rate environment. The REIT's $800 million war chest positions it as a primary "consolidator" in a fragmented market.
Categories
Topics
Related Coverage
- Healthpeak Properties Completes $600 Million Acquisition of South San Francisco Life Sciences Campus
- National Healthcare Properties Secures $462 Million in Public Debut Below Target Range
- Russia Curtails State Stimulus for Private Sector as Federal Deficit Surpasses Strategic Targets
- Drone manufacturer AEVEX targets $2.35 billion valuation in New York Stock Exchange debut